Topic
biotech-financing
1 stories related to this topic, newest first.
prnewswire.comfinance6 hrs agoSourced
Mira Pharmaceuticals Terminates $4.5 Million Securities Purchase Agreement
Mira Pharmaceuticals entered a material definitive agreement to terminate its April 2025 securities purchase agreement with an institutional investor. The move ends the company's obligation to sell up to $4.5 million in shares and removes associated registration rights.